Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at top drugmakers.

(RTTNews) - Gilead Sciences, Inc. (GILD), Wednesday announced that Merdad Parsey will step down from the role of Chief Medical Officer early next year. The company added that it has initiated the ...

Gilead Sciences, Inc. (Nasdaq: GILD) will present new data from the company’s broad lung cancer clinical development program ...

Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday. Gilead has ...

twice-yearly lenacapavir has demonstrated its potential as an important new tool to help prevent HIV infections,” said Gilead ...

came in remarks by Gilead's chief medical officer Merdad Parsey in the company's third-quarter results call. Parsey said the FDA has concerns about the "manufacture and delivery" of Hepcludex but ...

Multiple concurrent studies are helping inform whether remdesivir is a safe and effective treatment for COVID-19 and how to best utilize the drug,” said chief medical officer Merdad Parsey.

The speakers on today's call will be our chairman and chief executive officer, Daniel O'Day; our chief commercial officer, ...

which could significantly expand the number of patients who could be treated with our current supply of remdesivir," Gilead Chief Medical Officer Merdad Parsey said in a release. "This is ...

including those that may be susceptible to higher rates of COVID-19 infection, as well as others that are particularly vulnerable, including children and pregnant and postpartum women," Parsey added.

The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief ...

Gilead Sciences Inc Daniel O'Day; Chairman of the Board, Chief Executive Officer; Gilead Sciences Inc Johanna Mercier; Chief Commercial Officer; Gilead Sciences Inc Merdad Parsey; Chief Medical ...